Mestska nemocnice Ostrava

Ostrava 728 80

1 studies enrolling now · 4 studies all time

What they study most

Coronary Artery Disease, Coronary Heart Disease (CHD), Metabolic Dysfunction-Associated Steatotic Liver Disease, Ulcerative Colitis

Studies at this site

• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) — Recruiting now
• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
• Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies — Stopped early
• The Dual Antiplatelet Therapy Study (DAPT Study) — Completed